KR880011159A - 이미다조 디아제핀 유도체 - Google Patents
이미다조 디아제핀 유도체 Download PDFInfo
- Publication number
- KR880011159A KR880011159A KR1019880002420A KR880002420A KR880011159A KR 880011159 A KR880011159 A KR 880011159A KR 1019880002420 A KR1019880002420 A KR 1019880002420A KR 880002420 A KR880002420 A KR 880002420A KR 880011159 A KR880011159 A KR 880011159A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- cycloalkyl
- formula
- hydrogen
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- BMGXAZCDDYTVFV-UHFFFAOYSA-N imidazo[4,5-c]diazepine Chemical class C1=CN=NC2=NC=NC2=C1 BMGXAZCDDYTVFV-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 35
- 229910052739 hydrogen Inorganic materials 0.000 claims 20
- 239000001257 hydrogen Substances 0.000 claims 20
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 230000000694 effects Effects 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 12
- 229910052736 halogen Inorganic materials 0.000 claims 11
- 150000002367 halogens Chemical class 0.000 claims 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 7
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 6
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 6
- 208000019901 Anxiety disease Diseases 0.000 claims 5
- 230000036506 anxiety Effects 0.000 claims 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 229920006395 saturated elastomer Polymers 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 5
- GUJAGMICFDYKNR-UHFFFAOYSA-N 1,4-benzodiazepine Chemical class N1C=CN=CC2=CC=CC=C12 GUJAGMICFDYKNR-UHFFFAOYSA-N 0.000 claims 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 4
- 229910052794 bromium Inorganic materials 0.000 claims 4
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical group CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 3
- 206010010904 Convulsion Diseases 0.000 claims 3
- 102000004300 GABA-A Receptors Human genes 0.000 claims 3
- 108090000839 GABA-A Receptors Proteins 0.000 claims 3
- 229940049706 benzodiazepine Drugs 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 239000000460 chlorine Substances 0.000 claims 3
- 230000036461 convulsion Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 239000011737 fluorine Substances 0.000 claims 3
- 208000019116 sleep disease Diseases 0.000 claims 3
- 230000035882 stress Effects 0.000 claims 3
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- 206010039897 Sedation Diseases 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 230000001747 exhibiting effect Effects 0.000 claims 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- 102000005962 receptors Human genes 0.000 claims 2
- 108020003175 receptors Proteins 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- KUWLYYUCJPOHEX-UHFFFAOYSA-N 5-methyl-3-prop-1-ynyl-4h-imidazo[1,5-a][1,4]benzodiazepin-6-one Chemical compound C1N(C)C(=O)C2=CC=CC=C2N2C=NC(C#CC)=C21 KUWLYYUCJPOHEX-UHFFFAOYSA-N 0.000 claims 1
- HRYWLFKGTAIWGL-UHFFFAOYSA-N 7-chloro-3-(2-cyclopropylethynyl)-5-methyl-4h-imidazo[1,5-a][1,4]benzodiazepin-6-one Chemical compound N1=CN2C3=CC=CC(Cl)=C3C(=O)N(C)CC2=C1C#CC1CC1 HRYWLFKGTAIWGL-UHFFFAOYSA-N 0.000 claims 1
- MGWQSZRZJDZADX-UHFFFAOYSA-N 7-chloro-5-methyl-3-prop-1-ynyl-4h-imidazo[1,5-a][1,4]benzodiazepin-6-one Chemical compound C1N(C)C(=O)C2=C(Cl)C=CC=C2N2C=NC(C#CC)=C21 MGWQSZRZJDZADX-UHFFFAOYSA-N 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 206010021118 Hypotonia Diseases 0.000 claims 1
- 208000021642 Muscular disease Diseases 0.000 claims 1
- 201000009623 Myopathy Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000003042 antagnostic effect Effects 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 230000036640 muscle relaxation Effects 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 230000000506 psychotropic effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH88087 | 1987-03-10 | ||
| CH880/87-0 | 1987-03-10 | ||
| CH5988 | 1988-01-08 | ||
| CH59/88 | 1988-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR880011159A true KR880011159A (ko) | 1988-10-26 |
Family
ID=25683391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019880002420A Withdrawn KR880011159A (ko) | 1987-03-10 | 1988-03-09 | 이미다조 디아제핀 유도체 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4863920A (enExample) |
| EP (1) | EP0285837B1 (enExample) |
| KR (1) | KR880011159A (enExample) |
| AU (1) | AU604300B2 (enExample) |
| CA (1) | CA1327571C (enExample) |
| DE (1) | DE3872559D1 (enExample) |
| DK (1) | DK127288A (enExample) |
| ES (1) | ES2051781T3 (enExample) |
| FI (1) | FI880814A7 (enExample) |
| GR (1) | GR3005909T3 (enExample) |
| HU (1) | HU201763B (enExample) |
| IL (1) | IL85624A0 (enExample) |
| MC (1) | MC1918A1 (enExample) |
| NO (1) | NO167027C (enExample) |
| NZ (1) | NZ223736A (enExample) |
| PT (1) | PT86925B (enExample) |
| YU (1) | YU47988A (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1327572C (en) * | 1988-08-31 | 1994-03-08 | F. Hoffmann-La Roche Ag | Imidazodiazepine derivatives |
| GB8909700D0 (en) * | 1989-04-27 | 1989-06-14 | Roussel Lab Ltd | Chemical compounds |
| CA2015336A1 (en) * | 1989-05-19 | 1990-11-19 | F. Hoffmann-La Roche Ag | Imidazodiazepines for the treatment of neurological symptoms |
| EP0672047B1 (en) * | 1992-12-04 | 2003-05-02 | Janssen Pharmaceutica N.V. | ANTIALLERGIC IMIDAZO[1,2-a]THIENO[ 2,3-d]AZEPINE DERIVATIVES |
| KR20070033032A (ko) | 2004-07-16 | 2007-03-23 | 프로테오시스 악티엔게젤샤프트 | 세포보호제로서 ｐａｒｐ 및 ｓｉｒ 조절 활성을 갖는무스카린 길항제 |
| US20110294791A1 (en) | 2009-01-13 | 2011-12-01 | Proteosys Ag | Pirenzepine as an agent in cancer treatment |
| CA3004680A1 (en) | 2015-11-13 | 2017-05-18 | Mavalon Therapeutics Limited | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors |
| US11472806B2 (en) | 2017-05-12 | 2022-10-18 | Domain Therapeutics | Substituted heterocyclic compounds as allosteric modulators of group II metabotropic glutamate receptors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4280957A (en) * | 1974-09-11 | 1981-07-28 | Hoffmann-La Roche Inc. | Imidazodiazepines and processes therefor |
| ZA755418B (en) * | 1974-09-11 | 1977-06-29 | Hoffmann La Roche | Diazepine derivatives |
| CA1143728A (en) * | 1979-10-04 | 1983-03-29 | Max Gerecke | Imidazodiazepine derivatives |
| CA1174673A (en) * | 1981-02-27 | 1984-09-18 | Walter Hunkeler | Imidazodiazepines |
| DK151808C (da) * | 1982-11-16 | 1988-06-20 | Ferrosan As | Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater |
| DE3587913D1 (de) * | 1984-01-19 | 1994-10-06 | Hoffmann La Roche | Imidazodiazepin-Derivate. |
| DE3661197D1 (en) * | 1985-05-17 | 1988-12-22 | Ferrosan As | Oxadiazolylimidazobenzodiazepines, process for their preparation and pharmaceutical compositions |
| DK174086D0 (da) * | 1986-04-16 | 1986-04-16 | Ferrosan As | Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme |
| GB8720414D0 (en) * | 1987-08-28 | 1987-10-07 | Roussel Lab Ltd | Chemical compounds |
| CA1327572C (en) * | 1988-08-31 | 1994-03-08 | F. Hoffmann-La Roche Ag | Imidazodiazepine derivatives |
-
1988
- 1988-02-22 FI FI880814A patent/FI880814A7/fi not_active Application Discontinuation
- 1988-02-23 CA CA000559547A patent/CA1327571C/en not_active Expired - Fee Related
- 1988-03-03 US US07/163,441 patent/US4863920A/en not_active Expired - Fee Related
- 1988-03-03 NZ NZ223736A patent/NZ223736A/en unknown
- 1988-03-03 IL IL85624A patent/IL85624A0/xx unknown
- 1988-03-04 AU AU12710/88A patent/AU604300B2/en not_active Ceased
- 1988-03-07 MC MC881954A patent/MC1918A1/fr unknown
- 1988-03-07 HU HU881085A patent/HU201763B/hu not_active IP Right Cessation
- 1988-03-09 KR KR1019880002420A patent/KR880011159A/ko not_active Withdrawn
- 1988-03-09 DK DK127288A patent/DK127288A/da not_active Application Discontinuation
- 1988-03-09 PT PT86925A patent/PT86925B/pt not_active IP Right Cessation
- 1988-03-09 EP EP88103739A patent/EP0285837B1/de not_active Expired - Lifetime
- 1988-03-09 DE DE8888103739T patent/DE3872559D1/de not_active Expired - Lifetime
- 1988-03-09 NO NO881054A patent/NO167027C/no unknown
- 1988-03-09 YU YU00479/88A patent/YU47988A/xx unknown
- 1988-03-09 ES ES88103739T patent/ES2051781T3/es not_active Expired - Lifetime
-
1992
- 1992-10-08 GR GR920402228T patent/GR3005909T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3872559D1 (de) | 1992-08-13 |
| YU47988A (en) | 1991-04-30 |
| AU604300B2 (en) | 1990-12-13 |
| NO167027B (no) | 1991-06-17 |
| FI880814A7 (fi) | 1988-09-11 |
| AU1271088A (en) | 1988-09-15 |
| EP0285837B1 (de) | 1992-07-08 |
| NZ223736A (en) | 1992-01-29 |
| PT86925B (pt) | 1992-05-29 |
| NO167027C (no) | 1991-09-25 |
| PT86925A (pt) | 1988-04-01 |
| DK127288D0 (da) | 1988-03-09 |
| US4863920A (en) | 1989-09-05 |
| HUT47282A (en) | 1989-02-28 |
| GR3005909T3 (enExample) | 1993-06-07 |
| DK127288A (da) | 1988-09-11 |
| MC1918A1 (fr) | 1989-04-06 |
| NO881054D0 (no) | 1988-03-09 |
| FI880814A0 (fi) | 1988-02-22 |
| NO881054L (no) | 1988-09-12 |
| HU201763B (en) | 1990-12-28 |
| EP0285837A1 (de) | 1988-10-12 |
| CA1327571C (en) | 1994-03-08 |
| IL85624A0 (en) | 1988-08-31 |
| ES2051781T3 (es) | 1994-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kales et al. | Rebound insomnia and rebound anxiety: a review | |
| Lamb et al. | Self-injection of d, 1-3, 4-methylenedioxymethamphetamine (MDMA) in the baboon | |
| Campiani et al. | Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure | |
| US4076823A (en) | Triazolo-2,4-benzodiazepines | |
| CH616677A5 (enExample) | ||
| KR880011159A (ko) | 이미다조 디아제핀 유도체 | |
| Tribollet et al. | Binding of the non-peptide vasopressin V1a receptor antagonist SR-49059 in the rat brain: an in vitro and in vivo autoradiographic study | |
| PE105399A1 (es) | PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE 3a-(R)-BENCIL-2-METIL-2,3,3a,4,5,6,7-HEXAHIDRO-PIRAZOLO[4,3-c]PIRIDINA-3-ONA | |
| US20020128261A1 (en) | Cyclohepta [b] [1,4] diazepino [6,7, 1-hi] indoles and derivatives | |
| US4208417A (en) | Indole derivatives and their use as anxiolytics | |
| DE2065675A1 (de) | 1,3-dihydro-2h-1,4-benzodiazepin-2-onderivate und ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| CA1336823C (en) | Method of treating neurological disorders | |
| US3711470A (en) | 5-phenyl-7-bromo-1h-1,5-benzodiazepine-2,4-(3h,5h)-diones | |
| NO132933B (enExample) | ||
| DE2845406A1 (de) | 1-arylalkylimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende formulierungen | |
| DE2242059A1 (de) | 2,4-dihydro-1h-s-triazolo eckige klammer auf 4,3-a eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepine und verfahren zu ihrer herstellung | |
| DE69127572T2 (de) | Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-Störungen | |
| Mikol et al. | Isocarbostyrils from monomeric and dimeric. beta.-styryl isocyanates | |
| KR910007894A (ko) | 신규한 트리아졸로 유도체 및 이의 제조 방법 | |
| DE69013476T2 (de) | Anwendung von Naphthoxazinen. | |
| ATE42291T1 (de) | Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. | |
| KR900003173A (ko) | 이미다조디아제핀 유도체 | |
| DE2251291A1 (de) | Benzodiazepinderivate und verfahren zu ihrer herstellung | |
| US3457349A (en) | Esters of 1-aziridinepropionic acid as tranquilizers | |
| US3801569A (en) | 7-(1,1-difluoroalkyl)-1,4-benzodiazepines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19880309 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |